Droloxifene inhibits cortical bone turnover associated with estrogen deficiency in rats

This publication has 12 references indexed in Scilit:

• Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats
  Bone, 1995
• Droloxifene prevents ovariectomy-induced bone loss in tibiae and femora of aged female rats: A dual-energy X-ray absorptiometric and histomorphometric study
  Journal of Bone and Mineral Research, 1995
• Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats
  Endocrinology, 1995
• Prostaglandin E2 increased rat cortical bone mass when administered immediately following ovariectomy
  Bone and Mineral, 1993
• Pharmacologic and Biologic Properties of Droloxifene, A New Antiestrogen
  American Journal of Clinical Oncology, 1991
• Fracture risk: A role for compact bone
  Calcified Tissue International, 1990
• Prostaglandin E2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats
  Bone, 1990
• Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
  Journal of Bone and Mineral Research, 1987
• The effects of ovariectomy and 17β-estradiol on cortical bone histomorphometry in growing rats
  Journal of Bone and Mineral Research, 1987
• The relative contribution of trabecular and cortical bone to the strength of human lumbar vertebrae
  Calcified Tissue International, 1969